Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China · Delayed Price · Currency is CNY 13.26
-0.36 (-2.64%)
Sep 2, 2026, 3:00 PM CST
SHA:688658 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,054 | 10,050 | 6,405 | 9,387 | 8,694 | 13,370 | |
Market Cap Growth | -50.53% | 56.90% | -31.77% | 7.97% | -34.97% | 21.91% |
Enterprise Value | 5,315 | 9,366 | 5,531 | 8,438 | 7,036 | 11,081 |
Last Close Price | 13.62 | 22.61 | 14.41 | 20.64 | 18.35 | 27.16 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 51.77 | 50.80 | 25.94 | 24.52 |
Forward PE | - | 161.50 | 17.00 | - | - | - |
PS Ratio | 2.46 | 4.11 | 1.69 | 2.24 | 1.91 | 2.69 |
PB Ratio | 1.90 | 3.04 | 1.79 | 2.61 | 2.17 | 3.40 |
P/TBV Ratio | 1.98 | 3.19 | 1.88 | 2.75 | 2.28 | 3.57 |
P/FCF Ratio | 23.63 | 48.97 | 80.43 | 32.59 | - | 42.48 |
P/OCF Ratio | 16.96 | 29.53 | 14.62 | 11.95 | - | 25.95 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.16 | 3.83 | 1.46 | 2.01 | 1.55 | 2.23 |
EV/EBITDA Ratio | 209.78 | - | 13.39 | 22.03 | 17.85 | 15.62 |
EV/EBIT Ratio | - | - | 25.88 | 39.27 | 29.32 | 19.30 |
EV/FCF Ratio | 20.75 | 45.64 | 69.45 | 29.30 | - | 35.21 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.19 | 0.18 | 0.20 | 0.13 | 0.07 | 0.01 |
Debt / EBITDA Ratio | 24.36 | - | 1.67 | 1.18 | 0.69 | 0.05 |
Debt / FCF Ratio | 2.41 | 2.96 | 8.86 | 1.61 | - | 0.12 |
Net Debt / Equity Ratio | -0.22 | -0.24 | -0.22 | -0.28 | -0.35 | -0.61 |
Net Debt / EBITDA Ratio | -36.91 | 21.09 | -1.91 | -2.66 | -3.51 | -3.38 |
Net Debt / FCF Ratio | -2.80 | -3.96 | -9.89 | -3.54 | 2.07 | -7.62 |
Asset Turnover | 0.48 | 0.45 | 0.65 | 0.70 | 0.77 | 0.89 |
Inventory Turnover | 2.41 | 2.06 | 2.21 | 2.21 | 2.44 | 2.47 |
Quick Ratio | 1.55 | 1.21 | 1.54 | 1.21 | 1.59 | 2.00 |
Current Ratio | 1.98 | 1.54 | 2.10 | 1.60 | 2.05 | 2.42 |
Return on Equity (ROE) | -8.78% | -7.97% | 3.38% | 4.94% | 8.55% | 14.47% |
Return on Assets (ROA) | -2.14% | -2.69% | 2.29% | 2.25% | 2.56% | 6.42% |
Return on Invested Capital (ROIC) | -7.09% | -8.90% | 6.33% | 6.95% | 11.24% | 35.70% |
Return on Capital Employed (ROCE) | -4.70% | -6.70% | 5.00% | 5.70% | 5.80% | 14.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.43% | -2.61% | 1.93% | 1.97% | 3.85% | 4.08% |
FCF Yield | 4.23% | 2.04% | 1.24% | 3.07% | -7.70% | 2.35% |
Dividend Yield | - | - | - | 0.97% | 5.99% | 2.50% |
Payout Ratio | - | - | 89.92% | 273.34% | 91.88% | 37.58% |
Buyback Yield / Dilution | -0.04% | -0.65% | 1.97% | 0.49% | -0.51% | -25.37% |
Total Shareholder Return | -0.04% | -0.65% | 1.97% | 1.46% | 5.49% | -22.87% |